CL CHANNEL ACTIVITY AND FUNCTION IN SYSTEMIC SCLEROSIS MYOFIBROBLASTS
CL CHANNEL ACTIVITY AND FUNCTION IN SYSTEMIC SCLEROSIS MYOFIBROBLASTS
批准号:
7375445
负责人:
ARNOLD E POSTLETHWAITE
金额:
$0.52万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30
中文摘要
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。这项研究旨在检查硬皮病患者血液和皮肤细胞中的离子通道,将通道活性与健康对照细胞的活性进行比较,并观察阻断通道活性是否可以阻止肌成纤维细胞的形成。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is designed to examine the ion channel in cells in blood and skin from patients with scleroderma, to compare the channel's activity with cells from healthy controls and to see if blocking the channel's activity can prevent the formation of myofibroblasts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Vitamin D-Gelsolin-S1P Axis in Rheumatoid Arthritis
-
批准号:9412753
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Mechanism of action of 20-hydroxyvitamin D3 in dermal fibroblasts
-
批准号:8833514
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2014
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Chronic Sleep Restriction Increases Immunity to Autoantigen: Role of the SNS
-
批准号:7941787
-
项目类别:
-
资助金额:$41.84万
-
财政年份:2009
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Chronic Sleep Restriction Increases Immunity to Autoantigen: Role of the SNS
-
批准号:7830569
-
项目类别:
-
资助金额:$42.73万
-
财政年份:2009
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Novel Biosynthethic Pathway for Secosteroids and the Skin
-
批准号:8504632
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2006
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
OPEN LABEL MULTICENTER TRIAL OF ORAL CII TOLERANCE IN RA
-
批准号:7375424
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2005
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
ONE YEAR STUDY OF BOVINE TYPE I COLLAGEN VS PLACEBO IN SSC
-
批准号:7375427
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2005
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Pathogenic Mechanisms of Fibrosis:Common Ground
-
批准号:6777954
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2004
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
ONE YEAR STUDY OF BOVINE TYPE I COLLAGEN VS PLACEBO IN SSC
-
批准号:7206682
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2004
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
OPEN LABEL MULTICENTER TRIAL OF ORAL CII TOLERANCE IN RA
-
批准号:7206677
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2004
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Open Label Multicenter Trial of Oral CII Tolerance in RA
-
批准号:7041764
-
项目类别:
-
资助金额:$1.59万
-
财政年份:2003
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
One Year Study of Bovine Type I Collagen vs. Placebo in SSc
-
批准号:7041771
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2003
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Oral Administration of Lower Doses of Type I Bovine Collagen to Patients w/ Ssc
-
批准号:7041740
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2003
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Sleep Fragmentation Effects on Murine CII-Induced AR
-
批准号:6665501
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2002
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Sleep Fragmentation Effects on Murine CII-Induced AR
-
批准号:6561294
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2002
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
SCOR on the Pathogenesis of Scleroderma
-
批准号:6365313
-
项目类别:
-
资助金额:$86.13万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
Rheumatic Disease Research Core Center
-
批准号:6943000
-
项目类别:
-
资助金额:$55.21万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
SCOR on the Pathogenesis of Scleroderma
-
批准号:6659853
-
项目类别:
-
资助金额:$87.1万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
SCOR on the Pathogenesis of Scleroderma
-
批准号:6797753
-
项目类别:
-
资助金额:$88.94万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
SCOR on the Pathogenesis of Scleroderma
-
批准号:6532971
-
项目类别:
-
资助金额:$84.87万
-
财政年份:2001
-
负责人:ARNOLD E POSTLETHWAITE
-
依托单位:
国内基金
海外基金
同步辐射光源 channel-cut 晶体窄缝的游离微珠辅助化学机械抛光研究
-
批准号:21ZR1467700
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:王昆
-
依托单位:
经颅磁刺激对 Alzheimer病小鼠脑内homer1a-BK channel信号通路的影响及疗效评估
-
批准号:81371222
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:王芙蓉
-
依托单位: